Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Biotech Australia announces encouraging early clinical trial results with leg ulcer treatment

Sep. 4, 1998

Leo describes potent vitamin D3 derivatives with low calcemic activity

Sep. 3, 1998

Keratinocyte growth factor to enter phase II clinical trials

Sep. 3, 1998

Access signs development agreement with ViroTex for amlexanox formulations

Sep. 1, 1998

Access signs licensing agreement with Paladin to market amlexanox in Canada

Aug. 27, 1998

Incert appears to prevent the formation of postoperative adhesions

Aug. 26, 1998

Toray reports kappa agonists for treating dermatological disorders

Aug. 25, 1998

Access licensee files for U.K. approval of amlexanox oral paste

Aug. 24, 1998

Wound-healing asiatic acid derivatives under investigation at Dong Kook

Aug. 24, 1998

Wound-healing efficacy of PGI2 analogue confirmed in preclinical models

Aug. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...